Sign in

CIK 0001385818

  • Non-accelerated filer
  • Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
470883144
Phone
+1 720-437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Grant or award Director acquired 6,500 shares (grant or award)
  2. 4 Grant or award Director acquired 6,500 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 55,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 1,333,334 shares at $6.00 ($8,000,004)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Executive Officer acquired 450,000 shares (grant or award)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Director sold 5,108,921 shares at $1.82 ($9,298,236)
  16. 4 Open-market sale 10% owner sold 92,777 shares at $1.55 ($144,092)
  17. 4 Other acquisition Director acquired 108,920 shares (other)
  18. 4 Open-market sale Director sold 22,026,801 shares at an average $1.42 ($31,200,123)
  19. 4 Other acquisition Director acquired 335,279 shares (other)
  20. 3 Insider Initial Statement of Ownership

Page 5 of 10 · 187 filings